Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
IVD Medical Holding Yönetim
Yönetim kriter kontrolleri 4/4
IVD Medical Holding's CEO'su Kuk Sing Ho, Jun2019 tarihinde atandı, in görev süresi 5.33 yıldır. in toplam yıllık tazminatı CN¥ 3.70M olup, şirket hissesi ve opsiyonları dahil olmak üzere 99.8% maaş ve 0.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 10.8% ine doğrudan sahiptir ve bu hisseler HK$ 347.52M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.3 yıl ve 3 yıldır.
Anahtar bilgiler
Kuk Sing Ho
İcra Kurulu Başkanı
CN¥3.7m
Toplam tazminat
| CEO maaş yüzdesi | 99.8% |
| CEO görev süresi | 5.3yrs |
| CEO sahipliği | 10.8% |
| Yönetim ortalama görev süresi | 5.3yrs |
| Yönetim Kurulu ortalama görev süresi | 3yrs |
Son yönetim güncellemeleri
Recent updates
Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings
Sep 27
IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings
Aug 17Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding
Jun 07These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely
May 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 25IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 03IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings
Mar 30IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year
Mar 20If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity
Mar 06IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Feb 08Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Oct 22IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher
Oct 01IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
Aug 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556
Mar 22Returns At IVD Medical Holding (HKG:1931) Are On The Way Up
Feb 16Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?
Oct 16Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)
Sep 28IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet
May 16IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053
Apr 14IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 23IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Mar 16IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital
Jul 30These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well
May 04There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital
Apr 20IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year
Mar 05Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 15
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like
Jan 31A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Jan 16Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?
Jan 01How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?
Dec 17Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?
Dec 02IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.
Nov 19CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥260m |
| Mar 31 2024 | n/a | n/a | CN¥249m |
| Dec 31 2023 | CN¥4m | CN¥4m | CN¥238m |
| Sep 30 2023 | n/a | n/a | CN¥235m |
| Jun 30 2023 | n/a | n/a | CN¥232m |
| Mar 31 2023 | n/a | n/a | CN¥221m |
| Dec 31 2022 | CN¥5m | CN¥4m | CN¥210m |
| Sep 30 2022 | n/a | n/a | CN¥193m |
| Jun 30 2022 | n/a | n/a | CN¥177m |
| Mar 31 2022 | n/a | n/a | CN¥176m |
| Dec 31 2021 | CN¥4m | CN¥4m | CN¥175m |
Tazminat ve Piyasa: Kuk Sing 'ın toplam tazminatı ($USD 526.28K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 410.05K ).
Tazminat ve Kazançlar: Kuk Sing 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Kuk Sing Ho (64 yo)
5.3yrs
Görev süresi
CN¥3,700,000
Tazminat
Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & CEO | 5.3yrs | CN¥3.70m | 10.8% CN¥ 347.5m | |
| GM & Executive Director | 5.3yrs | CN¥2.16m | 6.93% CN¥ 223.1m | |
| CFO, Company Secretary & Executive Director | less than a year | Veri yok | Veri yok | |
| Executive Director | less than a year | Veri yok | Veri yok | |
| Financial Controller | 8.7yrs | Veri yok | Veri yok |
5.3yrs
Ortalama Görev Süresi
47yo
Ortalama Yaş
Deneyimli Yönetim: 1931 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.3 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & CEO | 8.4yrs | CN¥3.70m | 10.8% CN¥ 347.5m | |
| GM & Executive Director | 8.8yrs | CN¥2.16m | 6.93% CN¥ 223.1m | |
| CFO, Company Secretary & Executive Director | less than a year | Veri yok | Veri yok | |
| Executive Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | 5.3yrs | CN¥120.00k | Veri yok | |
| Independent Non-Executive Director | 5.3yrs | CN¥120.00k | Veri yok | |
| Non-Executive Director | 3yrs | Veri yok | Veri yok | |
| Non-executive Director | less than a year | Veri yok | Veri yok |
3.0yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 1931 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3 yıldır).